Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to placebo in patients with Duchenne ...
1. Cardiosphere-derived cell therapy (CAP-1002) slowed loss of upper limb function by 71% compared to placebo in patients with Duchenne ...
Originally published by Harvard Health. What Is It? Muscular dystrophy (MD) is a group of disorders that cause the body's ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.